Vaccitech Plc

( )
VACC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.93%54.040.9%$2015.04m
JNJJohnson & Johnson -0.82%165.210.7%$968.47m
ABBVAbbVie, Inc. -1.62%133.021.9%$895.75m
MRKMerck & Co., Inc. -0.69%80.730.7%$855.87m
BMYBristol-Myers Squibb Co. -0.17%64.611.0%$688.01m
LLYEli Lilly & Co. -0.76%243.201.1%$618.76m
AZNAstraZeneca Plc 1.16%60.171.0%$241.82m
NVSNovartis AG -0.75%88.180.2%$194.25m
GSKGlaxoSmithKline Plc -1.77%44.880.2%$162.29m
NVONovo Nordisk A/S -1.86%95.480.1%$152.14m
VTRSViatris, Inc. -0.54%14.640.0%$140.27m
RGENRepligen Corp. -0.59%188.466.7%$99.30m
IMMXImmix Biopharma, Inc. -4.24%5.420.0%$85.02m
ALLKAllakos, Inc. -3.37%7.180.0%$84.68m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.87%116.040.0%$72.25m

Company Profile

Vaccitech Plc operates as a holding company. It is engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company was founded in March 2021 and is headquartered in Oxford, the United Kingdom.